利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

185 条记录 (耗时 0.016 秒)

    1-Substituted aralkyl imidazoles
    52.
    发明授权
    1-Substituted aralkyl imidazoles 失效
    1-取代的芳烷基咪唑

    公开(公告)号：US4115578A

    公开(公告)日：1978-09-19

    申请号：US741440

    申请日：1976-11-12

    申请人： George A. Miller ,  Ronald P. Owen

    发明人： George A. Miller ,  Ronald P. Owen

    IPC分类号： C07C33/50 ,  C07D233/68 ,  C07D233/91 ,  C07D521/00 ,  C07D233/58 ,  A61K31/415

    CPC分类号： C07D233/56 ,  C07C33/50 ,  C07D231/12 ,  C07D233/68 ,  C07D233/91 ,  C07D249/08

    摘要： This disclosure describes novel aralkyl imidazoles, their acid addition salts, their metal complex salts and processes for their preparation. These compounds possess biological activity and in particular are useful as systemic protectant/eradicant fungicidal agents for controlling plant diseases caused by fungi and as plant growth regulators. The metal complex salts of these compounds are particularly useful in their ability to reduce undesirable plant growth regulatory activity and phytotoxicity while retaining their ability for controlling plant diseases caused by fungi.

    摘要翻译： 本公开描述了新的芳烷基咪唑，它们的酸加成盐，它们的金属络合盐及其制备方法。 这些化合物具有生物活性，尤其可用作用于控制由真菌引起的植物疾病和作为植物生长调节剂的系统性保护剂/根除杀真菌剂。 这些化合物的金属络合盐特别可用于减少不期望的植物生长调节活性和植物毒性，同时保留其控制由真菌引起的植物病害的能力。

    2-Nitroimidazol derivatives
    54.
    发明授权
    2-Nitroimidazol derivatives 失效
    2-硝基咪唑衍生物

    公开(公告)号：US3987053A

    公开(公告)日：1976-10-19

    申请号：US582556

    申请日：1975-05-29

    申请人： Bruno Cavalleri ,  Giancarlo Lancini

    发明人： Bruno Cavalleri ,  Giancarlo Lancini

    IPC分类号： C07D417/04 ,  C07D233/91

    CPC分类号： C07D417/04

    摘要： 2-Nitroimidazole derivatives of the general formula ##SPC1##Wherein R is a lower alkyl group and Y is a member of the group consisting of --CH.sub.2 OH, --CHO, CH.sub.3 CO--, vinyl, formylvinyl, styryl, substituted iminomethyl, 2-benzimidazolyl and 5-amino-1,3,4-thiadiazol-2-yl. The term "lower alkyl" designates aliphatic groups of from 1 to 4 carbon atoms; the term "substituted iminomethyl" designates nitrogen-containing functional derivatives of the aldehydic group. The compounds have antimicrobial activity.

    CLOSED EVAPORATION SYSTEM
    59.
    发明申请
    CLOSED EVAPORATION SYSTEM 审中-公开

    公开(公告)号：US20200043620A1

    公开(公告)日：2020-02-06

    申请号：US16555484

    申请日：2019-08-29

    申请人： GE HEALTHCARE LIMITED

    发明人： Xavier FRANCI ,  Steve LIGNON ,  Audrey LANGE

    IPC分类号： G21F9/08 ,  G21G4/08 ,  C07H19/06 ,  B01J19/00 ,  B01D1/30 ,  C07B59/00 ,  C07C227/40 ,  C07D233/91 ,  C07J1/00 ,  G21G1/00

    摘要： The present invention provides a system for evaporating a radioactive fluid, a method for the synthesis of a radiolabelled compound including this system, and a cassette for the synthesis of a radiolabelled compound comprising this system. The present invention provides advantages over known methods for evaporation of a radioactive fluid as it reduces drastically the amount of radioactive gaseous chemicals that are released in the hot cell. It is gentler and more secure compared to the known process and provides access to radiosyntheic processes that may not been acceptable for safety reasons related to release of volatile radioactive gases during evaporation. In addition, the process yields are higher because the radioactive volatiles are labelled intermediate species.